2020Chinese Journal of AsthmaRequires access

Study on the correlation between Pokemon protein and P14ARF-MDM2-p53 pathway proteins in non-small cell lung cancer

Lihong Wang, Yaping Dou, Shuangshuang Han, Haoran Xu, Jia Wang

Open publisher page 0 citations

Abstract

Objective To investigate the role of Pokemon protein and P14ARF-MDM2-p53 pathway proteins in the pathogenesis of non-small cell lung cancer (NSCLC). Methods This study included 35 NSCLC patients who underwent surgical treatment from the First Hospital of Hebei Medical University from October 2015 to October 2016.At the same time, 29 cases of normal bronchus stump adjacent to the cancer and 25 cases of pneumonia were used as the bronchial control group and alveolar control group, respectively.Immunohistochemistry was used to detect the expressions of Pokemon, P14ARF, MDM2 and p53 proteins in NSCLC group, bronchial control group and alveolar control group, and to analyze their relationship with clinicopathological data and their correlations. Results The expressions of Pokemon, MDM2 and p53 proteins in NSCLC group were significantly higher than those in the bronchial control group and the alveolar control group (all P values <0.01). The expression of P14ARF protein in NSCLC group was significantly lower than that in the bronchial control group and alveolar control group (χ2=25.39, P<0.01). The expressions of p53 and MDM2 protein were correlated with the degree of differentiation of NSCLC (P=0.02, 0.03). In NSCLC group, Pokemon was negatively correlated with P14ARF protein expression (r=-0.58, P<0.05), and P14ARF was negatively correlated with MDM2 protein expression (r=-0.51, P<0.05), MDM2 was positively correlated with p53 protein expression (r=0.86, P<0.05). Conclusions Pokemon plays an oncogene role in the pathogenesis of NSCLC by regulating the P14ARF-MDM2-p53 pathway. Key words: Carcinoma, non-small-cell lung; Immunohistochemistry; Pokemon; P14ARF; MDM2

About this research paper

What this paper is about

Objective To investigate the role of Pokemon protein and P14ARF-MDM2-p53 pathway proteins in the pathogenesis of non-small cell lung cancer (NSCLC). Methods This study included 35 NSCLC patients who underwent surgical treatment from the First Hospital of Hebei Medical University from October 2015 to October 2016.At the same time, 29 cases of normal bronchus stump adjacent to the cancer and 25 cases of pneumonia were used as the bronchial control group and alveolar control group, respectively.Immunohistochemistry was used to detect the expressions of Pokemon, P14ARF, MDM2 and p53 proteins in NSCLC group, bronchial control group and alveolar control group, and to analyze their relationship with clinicopathological data and their correlations. Results The expressions of Pokemon, MDM2 and p53 proteins in NSCLC group were significantly higher than those in the bronchial control group and the alveolar control group (all P values <0.01). The expression of P14ARF protein in NSCLC group was significantly lower than that in the bronchial control group and alveolar control group (χ2=25.39, P<0.01). The expressions of p53 and MDM2 protein were correlated with the degree of differentiation of NSCLC (P=0.02, 0.03). In NSCLC group, Pokemon was negatively correlated with P14ARF protein expression (r=-0.58, P<0.05), and P14ARF was negatively correlated with MDM2 protein expression (r=-0.51, P<0.05), MDM2 was positively correlated with p53 protein expression (r=0.86, P<0.05). Conclusions Pokemon plays an oncogene role in the pathogenesis of NSCLC by regulating the P14ARF-MDM2-p53 pathway. Key words: Carcinoma, non-small-cell lung; Immunohistochemistry; Pokemon; P14ARF; MDM2

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the role of Pokemon protein and P14ARF-MDM2-p53 pathway proteins in the pathogenesis of non-small cell lung cancer (NSCLC). Methods This study included 35 NSCLC patients who underwent surgical treatment from the First Hospital of Hebei Medical University from October 2015 to October 2016.At the same time, 29 cases of normal bronchus stump adjacent to the cancer and 25 cases of pneumonia were used as the bronchial control group and alveolar control group, respectively.Immunohistochemistry was used to detect the expressions of Pokemon, P14ARF, MDM2 and p53 proteins in NSCLC group, bronchial control group and alveolar control group, and to analyze their relationship with clinicopathological data and their correlations. Results The expressions of Pokemon, MDM2 and p53 proteins in NSCLC group were significantly higher than those in the bronchial control group and the alveolar control group (all P values <0.01). The expression of P14ARF protein in NSCLC group was significantly lower than that in the bronchial control group and alveolar control group (χ2=25.39, P<0.01). The expressions of p53 and MDM2 protein were correlated with the degree of differentiation of NSCLC (P=0.02, 0.03). In NSCLC group, Pokemon was negatively correlated with P14ARF protein expression (r=-0.58, P<0.05), and P14ARF was negatively correlated with MDM2 protein expression (r=-0.51, P<0.05), MDM2 was positively correlated with p53 protein expression (r=0.86, P<0.05). Conclusions Pokemon plays an oncogene role in the pathogenesis of NSCLC by regulating the P14ARF-MDM2-p53 pathway. Key words: Carcinoma, non-small-cell lung; Immunohistochemistry; Pokemon; P14ARF; MDM2

Key concepts: p14arf, Medicine, Lung cancer, P53 protein, Oncogene, Mdm2, Immunohistochemistry, Pathogenesis

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the correlation between Pokemon protein and P14ARF-MDM2-p53 pathway proteins in non-small cell lung cancer — Research Paper | ScholarLens